Sr.ProgramStrategyandOperationsDirector

## Description Remote | Full-Time | Monthly-travel | $275,000-$300,000 Everyone says they're reinventing drug discovery. We're proving it in the clinic. Enveda reads nature's chemistry with AI - the platform is built on it, and it finds new medicines ~4x faster than the industry standard. We reached unicorn status on a $150M Series D, our first medicines are now in clinical trials with a deep pipeline right behind them, and we're backed by Sanofi, Lux Capital, and Baillie Gifford, with former Pfizer R&D chief Mikael Dolsten on the board. The role You'll be the strategic and operational copilot to an Asset Entrepreneur driving one of our molecules, and the connective tissue across a single-threaded asset team. Think of it as the COO of a single-asset biotech, and an Asset Entrepreneur in the making: judged on the speed and quality of the asset's decisions, not on how many meetings you run. It's a front-row seat to drug development: full exposure across clinical, translational, regulatory, CMC, BD, and the boardroom at a fast-growing startup with a platform the industry doesn't have. ## What you'll do Distill scientific, clinical, regulatory, and operational inputs into clear insights and decisions for the C-suite Own program execution end-to-end - removing blockers, coordinating cross-functional dependencies, and keeping CRO partnerships and dashboards on track Serve as a strategic thought partner to the Asset Entrepreneur: anticipate inflection points, model scenarios, and help determine when to accelerate, pivot, or pause Bring rigor to every forum - Board updates, investor and BD discussions - with crisp slides, concise summaries, and decision-focused analyses Partner with functional experts across clinical, translational, regulatory, and CMC to integrate science and execution seamlessly Leverage AI and digital tools to organize complexity, accelerate workflows, and sharpen decision-making Contribute to Enveda's institutional intelligence by documenting benchmarks